Can magnetic waves tame autoimmune disease? new trial begins

NCT ID NCT07221565

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a non-invasive device that uses low-frequency electromagnetic fields to improve communication between immune cells. 120 adults with lupus, rheumatoid arthritis, or multiple sclerosis will receive either active or sham sessions three times a week for 12 weeks. The goal is to see if this approach can reduce flare-ups and symptoms safely.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Low-Frequency Electromagnetic Resonance Therapy (LF-EMR) device
What this could lead to
If it works, this could offer a non-invasive, drug-free way to reduce autoimmune flare-ups and improve symptom control for conditions like lupus, rheumatoid arthritis, and multiple sclerosis.
What could go wrong
This is an early-phase trial with only 120 participants, so results may not apply to everyone. The treatment is experimental, and its effectiveness and safety are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Truway Health, Inc. www.truwayhealth.com (401 E 34th Street, S11P, New York, NY 10016)

    New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.